Back
ESC Professional Premium Access

Valsartan reduces arterial stiffness along with level of soluble ST2 independently of blood pressure changes

Session: Hypertension - Pharmacotherapy
Topic: Pharmacotherapy
Speaker: Doctor A. Tomasik (Zabrze, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Andrzej Tomasik

The Medical University of Silesia, Zabrze (Poland)
0 follower

7 more presentations in this session

Intensive reduction of high normal blood pressures: PRINT-TAHA9 randomized clinical trial

Speaker: Associate Professor A. Attar (Shiraz, IR)

Access
Abstract
Slides
Like
Thumbnail

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Speaker: Doctor M. Freeman (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Differentiated approach to the treatment of uncomplicated hypertensive crisis

Speaker: Doctor M. Sadulloeva (Tashkent, UZ)

Access
Abstract
Slides
Like
Thumbnail

Blockade of the renin-angiotensin system as a therapeutic target of NAFLD: results of an experimental model of hypercholesterolemia

Speaker: Professor D. Bertolim Precoma (Campina Grande do Sul, BR)

Access
Abstract
Slides
Like
Thumbnail

Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study

Speaker: Doctor F. Goetzinger (Homburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Hypertension - Pharmacotherapy

Speakers: Doctor A. Tomasik, Associate Professor A. Attar, Doctor M. Freeman, Doctor M. Sadulloeva, Professor D. Bertolim Precoma...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources